Navigation Links
Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
Date:11/11/2009

-------- -------- -------- -------- 3,185 14 5,720 (114) -------- -------- -------- -------- Net loss......................... (5,945) (3,569) (14,748) (13,599) Other comprehensive income....... - 31 - - -------- -------- -------- -------- Comprehensive net loss........... $ (5,945) $ (3,538) $(14,748) $(13,599) -------- -------- -------- -------- -------- -------- -------- -------- Basic and diluted loss per share........................... $ (0.24) $ (0.18) $ (0.68) $ (0.70) -------- -------- -------- -------- -------- -------- -------- -------- Weighted average number of common shares outstanding....... 24,714 19,492 21,749 19,490 -------- -------- -------- -------- -------- -------- -------- -------- Oncothyreon Inc. Consolidated Balance Sheets Data (in thousands) (unaudited) September, 2009 December 31, 2008 Cash, cash equivalents..................... $ 34,980 $ 19,166 Total assets............................... $ 39,625 $ 24,971 Total long-term liabilities................ $ 10,303 $ 393 Stockholders' equity....................... $ 26,936 $ 20,717 Common shares outstanding.................. 25,662 19,492

SOURCE Oncothyreon Inc.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Oncothyreon announces webcast of third quarter 2009 financial results conference call
2. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
3. Oncothyreon to present at Rodman Renshaw Global Healthcare Conference
4. Oncothyreon reports second quarter 2009 financial results
5. Oncothyreon announces closing of $15.0 million registered direct financing
6. Oncothyreon announces webcast of second quarter 2009 financial results conference call
7. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
8. Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
9. Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
10. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
11. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... , May 16, 2013 Scientists at the ... Beijing , and the California ... demonstrated a novel therapy for reversing memory decline in ... they find significant cognitive improvement in advanced stage AD ... mechanism for reversing cognitive decline for advanced stage AD ...
(Date:5/16/2013)... , May 16, 2013 /PRNewswire/ ... market research report is available in ... Competitor Analysis: Therapeutic Proteins ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ...   The new Competitive ...
(Date:5/16/2013)... May 16, 2013 DNA Genotek, a leading ... for Africa’, a sponsorship program in conjunction with the African ... to improve access and reduce the cost of DNA ... as the Human Heredity and Health in Africa (H3 Africa) ... , The aim of the AfSHG is to ...
(Date:5/16/2013)... New York, NY (PRWEB) May 16, 2013 ... PRMA Insights: Market Access Success for Companion Diagnostic–Drug ... the key issues that biopharmaceutical manufacturers should understand ... medicine is gaining traction, particularly in oncology, with ... NSCLC and Zelboraf for BRAF-mutation positive melanoma. Payors ...
Breaking Biology Technology:Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3Market Access Expert Firm, PRMA Consulting, Launches Companion Diagnostics Handbook 2
... from around the world came together today to share their ... (CVBD) forum in Nice, France and call for greater awareness ... increasingly important diseases. "A number of the ... many CVBDs represent a zoonotic risk. It,s vital that veterinarians ...
... of our electronic age rests on our ability to ... point B, through circuitry. Doing so requires particular precision, ... cells, and that task falls to semiconductors. Now, ... of Engineering and Applied Science and Arts and Sciences ...
... at the Hilton San Francisco Union Square, Pam Marrone ... (MBI), will address Agriculture 2.0 conference attendees as ... a Growing Global Population,. The discussion will explore technologies with ... to feed a projected world population of 9 billion people ...
Cached Biology Technology:Veterinarians and Pet Owners Urged to Act Upon Evolving Dangers Posed by CVBDs as New Research Underlines Threats to Animals and Humans 2Veterinarians and Pet Owners Urged to Act Upon Evolving Dangers Posed by CVBDs as New Research Underlines Threats to Animals and Humans 3Veterinarians and Pet Owners Urged to Act Upon Evolving Dangers Posed by CVBDs as New Research Underlines Threats to Animals and Humans 4Penn research advances understanding of lead selenide nanowires 2Penn research advances understanding of lead selenide nanowires 3Pam Marrone to Speak at Ag 2.0 Conference 2
(Date:5/18/2013)... FL (May 18, 2013) An increasing number ... require interventions to resolve, according to research presented ... one study targeting obesity, researchers at the Cleveland ... a unique pattern of exhaled breath compared to ... volatile organic compound levels that can be correlated ...
(Date:5/17/2013)... 18, 2013) The AGA Research Foundation announced a ... relationship between the gut microbiota, one of today,s most ... , The AGA Research Awards Panel selected Andrew ... General Hospital and Harvard Medical School, Boston, as the ... Chan will receive $25,000 of funding, commencing in July ...
(Date:5/17/2013)... white noise of the South, but the night belongs to ... hangs heavy from the humidity and the sounds of wildlife. ... of frogs, toads and salamanders, is the center of amphibian ... are the auditorium for their symphonic choruses, the scientists of ... ARMI, have front-row seats. , Amphibians, which rely ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3New gut microbiome research to explore red meat -- colorectal cancer pathway 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... Commercial flower and plant growers know all too ... the value and deterring healthy growth of potted ornamental ... to the expensive practice of paying workers to hand-weed ... is questionable on the wide range of plant species ...
... Tactile Sensors at Your Fingertips, Literally, ... Systems, Inc.,(PPS) today announces their innovative new ... immediate sale worldwide. FingerTPS,sensors are soft, flexible ... accurate,repeatable tactile force data to a PC ...
... reports from TRAFFIC, the world,s largest wildlife trade ... and Vietnam suggest that illegal wildlife trade, including ... the region,s rich and varied biodiversity and putting ... The results of field studies carried ...
Cached Biology News:Ethanol byproduct produces green results 2Wearable Sensors Conceived at Harvard Robotics Lab Measure Hand Forces 2A bitter pill to swallow 2
... useful for routine procedures. Hollandes contains formaldehyde ... will decalcify small bone specimens. Tissue that ... successfully with most stains, and the cupric ... cell membranes and cosinophil and endocrine cell ...
... In Vitro Osteogenesis Assay Kit contains all ... a mature osteoblastic lineage, as determined by ... provides all the necessary reagents and a ... plate reader. This product is useful for ...
... standard for automated bioresearch: Developed for ... • Based on decades of experience ... designed for bioresearch • Holographic gratings ... reliability and ease-of-use • Pulsed Xenon ...
... MSn data, the patent-pending Formula Predictor ... of fragmentation, isotope pattern verification, and ... determine the correct formula for unknown ... deducing empirical formulae from mass spec ...
Biology Products: